SFX by Ex Libris Inc.

Title:	Eradication of established tumors in mice by a combination antibody-based therapy
Source:	Nature Medicine [1078-8956] Uno, Tomoyasu yr:2006

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Curiel, Tyler J J. "Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity." Nature medicine 9.5 (2003): 562-7.
description	2.	Curiel, Tyler J. "Murder or Mercy? Hurricane Katrina and the Need for Disaster Training." The New England journal of medicine 355.20 (2006): 2067-9.
description	3.	Ochi, H. "Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4(+) CD25(-)LAP(+) T cells." Nature medicine 12.6 (2006): 627-635.
description	4.	Mounho, D. "Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions." Nature Medicine 7.4 (2001): 383-385.
description	5.	Booy, Evan P P. "Monoclonal and bispecific antibodies as novel therapeutics." Archivum immunologii et therapiae experimentalis 54.2 (2006): 85-101.
description	6.	Chen, L. "Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion." Nature medicine 8.8 (2002): 793-800.
description	7.	Chatenoud, L. "Weaned from the needle." Nature medicine 12.6 (2006): 617-8.
description	8.	Lugosi, Charles I I. "Natural disaster, unnatural deaths: the killings on the life care floors at Tenet's Memorial Medical Center after Hurricane Katrina." Issues in law & medicine 23.1 (2007): 71-85.
description	9.	Currier, M. "A Katrina experience: lessons learned." The American journal of medicine 119.11 (2006): 986-92.
description	10.	Mason, Diana J J. "In their shoes: Two nurses and a physician have been accused of murder during the Katrina disaster." The American journal of nursing 106.10 (2006): 11-11.
description	11.	Pou, A. "Hurricane Katrina and Disaster Preparedness." New England Journal of Medicine, The 358.14 (2008): 1524-1524.
description	12.	Frenkel, D. "Immunology and immunotherapy of Alzheimer's disease." Nature reviews. Immunology 6.6 (2006): 404-16.
description	13.	Riding, A. "Murder, Booze and Misery: A Female Cop's Last Hurrah." The New York times 156.53757 (2006).
description	14.	Bettelli, E. "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells." Nature 441.7090 (2006): 235-238.
description	15.	KATO, K. "Therapeutic Monoclonal Antibodies for Cancer: The Past, Present, and Future." 順天堂醫事雑誌 61.6 (2015): 601-607.
description	16.	Koschny, H. "TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window." Hepatology 45.3 (2007): 649-58.
description	17.	Kyung-Ok, L. "The Therapeutic Potential of 4-1BB (CD137) in Cancer." Current cancer drug targets 5.5 (2005): 357-63.
description	18.	Maisey, N. "Antitumor Necrosis Factor (TNF-a) Antibodies in the Treatment of Renal Cell Cancer." Cancer investigation 25.7 (2007): 589-593.
description	19.	DeForge, A. "Safety and antitumor activity of recombinant soluble Apo2 ligand." The journal of clinical investigation 104.2 (1999): 155-62.
description	20.	Kim, R. "Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy." Cancer gene therapy 14.1 (2007): 1-11.